DANZITEN vs ICLUSIG

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. DANZITEN and ICLUSIG are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	ICLUSIG
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	PONATINIB HYDROCHLORIDE
Manufacturer	Azurity	Takeda Pharms USA
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Myeloid Leukemia

danziten iclusig

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

NILOTINIB TARTRATE

PONATINIB HYDROCHLORIDE

Manufacturer

Azurity

Takeda Pharms USA

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Myeloid Leukemia

Frequently asked questions

What is the difference between Danziten and Iclusig?

Danziten contains Nilotinib Tartrate, while Iclusig contains Ponatinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.